期刊文献+

艾滋病疫苗的研究进展 被引量:2

Research progress of AIDS vaccine
原文传递
导出
摘要 艾滋病是由艾滋病病毒引起的危害性极大的传染病,预防该疾病的重要手段是接种有效的疫苗。虽然艾滋病疫苗还未曾出世,但是近年来艾滋病疫苗的研究有了很多重大突破。目前艾滋病疫苗的种类主要包括传统疫苗(灭活疫苗和减毒活疫苗)和新型疫苗(病毒样颗粒、合成多肽疫苗、蛋白亚单位疫苗、脱氧核糖核酸疫苗、载体疫苗)。现如今多种艾滋病疫苗已进入临床试验。本文旨在对现阶段艾滋病疫苗研究进展进行综述。 AIDS is a dangerous infectious disease caused by human immunodeficiency virus.The important means to prevent the disease is to inoculate the effective vaccine.Although AIDS vaccine has not yet been available,AIDS vaccine research has made many breakthroughs in recent years.At present,the types of AIDS vaccines mainly include traditional vaccines(inactivated vaccine and live attenuated vaccine)and new vaccines(virus like particles,synthetic peptide vaccines,protein subunit vaccines,DNA vaccines,carrier vaccines).A variety of AIDS vaccines are in clinical trials.This paper is to review the progress of AIDS vaccine research.
作者 孙达 邵丽军 王颖 伊正君 李猛 SUN Da;SHAO Lijun;WANG Ying;YI Zhengjun;LI Meng(Department of Laboratory Medicine,Weifang Medical University,Weifang 261053,Shandong,China;School of Public Health and Management,Weifang Medical University,Weifang 261053,Shandong)
出处 《中国艾滋病性病》 CAS CSCD 北大核心 2019年第4期421-424,共4页 Chinese Journal of Aids & STD
基金 山东省自然科学基金(ZR2017LH055)~~
关键词 艾滋病 疫苗 研究进展 AIDS Vaccine Research progress
  • 相关文献

参考文献5

二级参考文献47

  • 1臧春鹏,汪宁.抗病毒治疗在阻断艾滋病传播流行中的作用[J].中华临床医师杂志(电子版),2011,5(8):2343-2346. 被引量:18
  • 2我国自行研制的艾滋病疫苗进入I期临床试验[J].中国药事,2004,18(12):755-755. 被引量:1
  • 3任莉,仇超,黄相刚,潘翔,徐建青,邵一鸣.HIV-1 B'亚型gag-env融合基因的DNA疫苗构建和免疫原性分析[J].中华微生物学和免疫学杂志,2006,26(7):654-658. 被引量:3
  • 4Burgers W A, Van Harmelen J H, Shephard E, et al. De- sign and preclinical evaluation of a multigene human immuno- deficiency virus type 1 subtype C DNA vaccine for clinical tri- al [J] . J Gen Virol, 2006, 87 (Pt2): 399-410.
  • 5邵一鸣,罗夫·伟格拿,汉思·渥夫.HIV-1亚型间(C/B)基因组和其用途:中国,CNl423698[P].2003-6-11.
  • 6Wilkening S, Bader A. Quantitative real time polymerase chain reaction methodical analysis and mathematical model [J].J Biomol Tech, 2004, 15 (2) : 107-111.
  • 7Hyndman D L, Mitsuhashi M. PCR primer design[J]. Met hods Mol Biol, 2003, (226) : 81-88.
  • 8Walker L E, Vang L, Shen X, development of a recombinant mixed format vaccine to deliver epitopes [J] . Vaccine, 2009, 27 et al. Design and preclinical protein and DNA plasmid HIV-derived T-lymphocyte (50) :7087-7095.
  • 9Snodin D J, Ryle P R. Understanding and applying regulato- ry guidance on the nonclinical development of biotechnology- derived pharmaceuticals [J].Bio Drugs, 2006, 20 (1): 25-52.
  • 10FDA. Guidance for Industry: Gene therapy clinical trials-ob- serving subjects for delayed adverse events [EB/OL] . (2006-11) [2011-07-28] . http://www. fda. gov/Biologics- BloodVaecines/GuidanceComplianceRegulatoryInformation/ Guidances/CellularandGeneTherapy/ucm072957. htm.

共引文献4

同被引文献19

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部